PAG
GILD icon

Private Advisor Group’s Gilead Sciences GILD Stock Holding History

Private Advisor Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-37,700
Closed -$28.3K – 2335
2023
Q3 		$28.3K Buy
+37,700
New +$2.9M ﹤0.01% 2073
2015
Q1 		– Sell
-400
Closed -$3K – 1030
2014
Q4 		$3K Buy
+400
New +$41.4K ﹤0.01% 992

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Private Advisor Group's GILD Position: Q1 2026 in Review

Private Advisor Group increased its Gilead Sciences (GILD) stake by 8.7% in Q1 2026, buying an estimated $562K and bringing the position to 50,035 shares worth $6.97M. The position accounts for 0.03% of the portfolio, ranked #511.

Private Advisor Group first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $9.76M in Q3 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Private Advisor Group held 50,035 shares of Gilead Sciences worth $6.97M as of Q1 2026.
  • Private Advisor Group bought 4,010 Gilead Sciences shares in Q1 2026, an estimated $562K.
  • Gilead Sciences made up 0.03% of Private Advisor Group's portfolio in Q1 2026, its #511 holding.
  • Private Advisor Group first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Private Advisor Group's Gilead Sciences position peaked at $9.76M in Q3 2021.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.